Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.65)
# 1,922
Out of 4,814 analysts
17
Total ratings
66.67%
Success rate
9.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $32 → $26 | $0.62 | +4,066.00% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.91 | +5,395.11% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $19.67 | +103.36% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $3.00 | +5,566.67% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $4.30 | +365.12% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $25.97 | +92.53% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $100.34 | +43.51% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $32 → $26
Current: $0.62
Upside: +4,066.00%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.91
Upside: +5,395.11%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $19.67
Upside: +103.36%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $3.00
Upside: +5,566.67%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $4.30
Upside: +365.12%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $25.97
Upside: +92.53%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $100.34
Upside: +43.51%